A Xp22.11-p21.3 microdeletion in a three-generation family supports male lethality of POLA1 nullisomy resulting in reduced fertility of female carriers

Eur J Med Genet. 2022 Dec;65(12):104628. doi: 10.1016/j.ejmg.2022.104628. Epub 2022 Sep 29.

Abstract

POLA1 encodes a subunit of the DNA polymerase alpha, a key enzyme for the initiation of DNA synthesis. In males, hemizygous hypomorphic variants in POLA1 have been identified as the cause of X-linked pigmentary reticulate disorder (XLPDR) and a novel X-linked neurodevelopmental disorder termed Van Esch-O'Driscoll syndrome (VEODS), while female carriers have been reported to be healthy. Nullisomy for POLA1 was speculated to be lethal due to its crucial function, while the effect of loss of one allele in females remained unknown. Here, we report on a three-generation family harboring a deletion of POLA1 in females showing subfertility as the only phenotype. Our findings show that heterozygous deletions or truncating variants in females with skewed X inactivation do not cause VEODS and support the hypothesis of very early embryonic lethality in males with POLA1 nullisomy.

Keywords: DNA polymerase alpha; Early pregnancy loss; Fertility; POLA1; Van Esch-O’Driscoll syndrome.

MeSH terms

  • DNA Polymerase I / genetics
  • Female
  • Fertility
  • Genes, X-Linked
  • Genetic Diseases, X-Linked* / genetics
  • Heterozygote
  • Humans
  • Intellectual Disability* / genetics
  • Male

Substances

  • DNA Polymerase I